| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |